We examined the liver cancer stem cell or progenitor markers (AFP, CD133, EPCAM, and KRT19), and hepatocyte terminal differentiation markers (ALB, G6PC, CYP3A4, and HNF4A) in subgroup of patients with different SOX signature scores. This evidence concerns the gene EPCAM and liver cancer.